Tag Archives: Biopharmaceutical

The New York Stock Exchange is Getting Its First Weed Fund

The New York Stock Exchange Is Getting Its First Weed Fund

The New York Stock Exchange Is Getting Its First Weed Fund

A subsidiary of the New York Stock Exchange launches trading on Dec. 26 for its first-ever marijuana fund, a major step for an industry that’s struggled to access mainstream U.S. financial instruments, even as Canadian markets have kicked off marijuana investment.

Sean Murphy Weighs in on the Future of Medical Cannabis

Sean Murphy Weighs in on the Future of Medical Cannabis

At the California Cannabis Business Expo on March 8, 2017, entrepreneurs and investors interested in the science and technology of medical cannabis were given a crash course in the future of cannabis, and cannabidiol, as an alternative to pharmaceuticals by Hemp Business Journal founder Sean Murphy.

GWPH Phase 3 Results

GW Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference

LONDON, Sept. 7, 2016 /Weed Wire/ — GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced that Justin Gover, GW’s Chief Executive Officer, is scheduled to present at the Morgan Stanley Global Healthcare Conference.

Nemus Bioscience

NEMUS Bioscience, Inc. Signs Agreement With Albany Molecular Research Inc. (AMRI) to Manufacture Cannabinoid-Based Active Pharmaceutical Ingredients

COSTA MESA, Calif., and Albany, N.Y., Feb. 8, 2016/ Weed Wire/ —NEMUS Bioscience, Inc. (OTCQB: NMUS) today announced an agreement with Albany Molecular Research Inc. (NASDAQ: AMRI) for the development and manufacture of NEMUS’ proprietary cannabinoid-based active pharmaceutical ingredients.


Top